Children with osteogenesis imperfecta treated with bisphosphonates have site-specific bone responses to therapy.

被引：0
|
作者：
Fuchs, RK
Peacock, M
McClintock, C
DiMerlio, LA
机构：
[1] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA
[2] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN USA
[3] Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46202 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2005年 / 20卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [21] Pamidronate therapy in children with osteogenesis imperfecta: Effect on the bone material level.
    Weber, M
    Roschger, P
    Rauch, F
    Schoeberl, T
    Fratzl-Zelman, N
    Glorieux, FH
    Fratzl, P
    Klaushofer, K
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S99 - S99
  • [22] BONE MINERAL CHANGES AND FRACTURE OUTCOMES IN 27 CHILDREN WITH OSTEOGENESIS IMPERFECTA TREATED BY PAMIDRONATE
    Kostik, M. M.
    Idrisova, R. V.
    Chikova, I. A.
    Isupova, E. A.
    Kalashnikova, O. V.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S534 - S534
  • [23] INCREASED BONE-MINERAL DENSITY IN FLUORIDE-TREATED CHILDREN WITH OSTEOGENESIS IMPERFECTA
    CHRISTENSON, RA
    BAYLINK, DJ
    CLINICAL RESEARCH, 1988, 36 (01): : A214 - A214
  • [24] Site-specific gene editing with ABBIE for T-cell therapy.
    Park, Jihyun
    Wang, Xiaohong
    Mirandola, Leonardo
    Chiriva-Internati, Maurizio
    CANCER RESEARCH, 2021, 81 (13)
  • [25] Site-specific antibody conjugation of metal chelators for nuclear imaging and therapy.
    Ahn, Shin Hye
    Thach, Daniel
    Vaughn, Brett
    Boros, Eszter
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [26] Development of magnetic retroviral vectors for site-specific targeting in skeletal gene therapy.
    Chen, ST
    Tai, MF
    Chi, KM
    Wen, MC
    Rundle, CH
    Lau, KHW
    Baylink, DJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S278 - S278
  • [27] Bone response to jumping is site-specific in children: a randomized trial
    Johannsen, N
    Binkley, T
    Englert, V
    Neiderauer, G
    Specker, B
    BONE, 2003, 33 (04) : 533 - 539
  • [28] Bone mass, size, and density in children and adolescents with osteogenesis imperfecta: Effect of intravenous pamidronate therapy
    Rauch, F
    Plotkin, H
    Zeitlin, L
    Glorieux, FH
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (04) : 610 - 614
  • [29] BONE MINERAL ACCRUAL AND FRACTURE OUTCOMES IN CHILDREN WITH OSTEOGENESIS IMPERFECTA TREATED BY PAMIDRONATE: SINGLE CENTER EXPERIENCE
    Kostik, M.
    Chikova, I.
    Buchinskaya, N.
    Kalashnikova, O.
    Scheplyagina, L.
    Larionova, V.
    OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S329 - S329
  • [30] Evidence that abnormal high bone mineralization in growing children with osteogenesis imperfecta is not associated with specific collagen mutations
    Roschger, Paul
    Fratzl-Zelman, Nadja
    Misof, Barbara M.
    Glorieux, Francis H.
    Klaushofer, Klaus
    Rauch, Frank
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (04) : 263 - 270
12345